Try one of the below options to narrow down your search.
 |
Documents may be browsed by date, eg; Today, May, 2013.
Past years can be browsed too, eg; 2012, 2011, 2010, 2009 ...
Documents can be searched within a period by browsing to the date and then using the search form; or by direct links, eg; Media releases from 2013
Document tags (shown below the document date, eg; Schedule, SAForms, consultation ...) have highest priority when search results are ranked, followed by title, abstract and full text of document.
Parentheses and the keywords and, or and not have special meaning in search terms. And is implicit and can be omitted; or must be specified.
Remember to group or statements with parentheses if they are beside and statements.
Search examples
- consultation
- Search for consultations
- media and not antibiotics
- Search for media related documents that don't mention antibiotics.
- (media or consultation) and vaccines
- Search for media releases and consultation documents mentioning vaccinations.
Search term:
2011
PHARMAC documents that matched your search:
Further information regarding proposal to fund bortezomib (Velcade); Contact: Jackie Evans
(1 page, 103 KB)
2011/01/12
12 January 2011 Suspension of proposal to fund bortezomib for patients with multiple myeloma On 15th December 2010 PHARMAC consulted on a proposal to fund bortezomib (Velcade) for patients with multiple myeloma through a provisional agreement with Janssen-Cilag Pty Limited.…
PHARMAC Chief Executive's invitation to respond to EC consultation
(2 pages, 105 KB)
2011/01/10
10 January 2011 REVIEW OF PHARMAC’S EXCEPTIONAL CIRCUMSTANCES POLICY Greetings and happy New Year. You will recall that we sought your views on our discussion document, PHARMAC’s Review of Exceptional Circumstances: Seeking Your Views, in August 2010. We received more…
PHARMAC consulting on Exceptional Circumstances scheme
(1 page, 63 KB)
2011/01/10
10 January 2011 Media release PHARMAC’s Consultation on Exceptional Circumstances PHARMAC is seeking feedback on proposed changes to its Exceptional Circumstances policy. Currently the three exceptional circumstances schemes provide pharmaceutical funding consideration for patients in rare or unusual medical situations,…
Review of Exceptional Circumstances: Consultation on Proposed Changes
(34 pages, 377 KB)
2011/01/10
Pharmaceutical Management Agency Review of Exceptional Circumstances Consultation on Proposed Changes January 2011 1 Table of contents 1. Context and review process….. 3 a. Origins and aims…. 3 b. Process to date… 3 c. Seeking your feedback … 3 i.…
Summary of Submissions to Review of Exceptional Circumstances: Seeking Your Views
(25 pages, 935 KB)
2011/01/10
Pharmaceutical Management Agency January 2011 Review of Exceptional Circumstances Summary of submissions in response to Seeking Your Views (August 2010) Executive summary PHARMAC issued a discussion document, Review of Exceptional Circumstances: Seeking Your Views, in August 2010. This document…
